Evidence map›Paper›PMID 34895158›Full record

ArticleBMC infectious diseases2021

Toxocariasis affecting brain stem and skull base.

Manuel Gomez Serrano, Rafael Jimenez Rodriguez-Madridejos, Salome Merino Menendez, Diana Maria Hernanperez Hidalgo, Jesus Gimeno Hernández, Maria Cruz Iglesias Moreno

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Manuel Gomez SerranoENT Department, Hospital Clínico San Carlos, Universidad Complutense, Calle Profesor Martin Lagos s/n. 5ª Planta, Madrid, Spain. manuelgts@hotmail.com.ORCID http://orcid.org/0000-0002-6560-2278
Rafael Jimenez Rodriguez-MadridejosInternal Medicine Consultant. Internal Medicine Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain.
Salome Merino MenendezRadiology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain.
Diana Maria Hernanperez HidalgoENT Department, Hospital Clínico San Carlos, Universidad Complutense, Calle Profesor Martin Lagos s/n. 5ª Planta, Madrid, Spain.
Jesus Gimeno HernándezENT Department, Hospital Clínico San Carlos, Universidad Complutense, Calle Profesor Martin Lagos s/n. 5ª Planta, Madrid, Spain.
Maria Cruz Iglesias MorenoENT Department, Hospital Clínico San Carlos, Universidad Complutense, Calle Profesor Martin Lagos s/n. 5ª Planta, Madrid, Spain.
Hospital Clínico San Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundToxocariasis is a helminthic infection caused by a nematode that mainly affects populations in tropical and subtropical latitudes. Humans are potential paratenic hosts, and clinical disease occurs as a result of parasite migration through intestinal tissue. We present a clinical case of otorhinolaryngological affectation by Toxocara canis. CASE PRESENTATION: A 60-year-old male from Ecuador, resident in Spain for 5 years, evaluated in the emergency department for presenting headache, otorrhea and left ear pain. Computed tomography (CT) and magnetic resonance imaging (MRI) reported a large mass of the nasopharynx with infiltration of the skull base, intracranial extension and a lesion in the left pons without being able to exclude metastases. Two Functional Endoscopic Sinus Surgery (FESS) biopsies were negative for malignancy. Despite not meeting the diagnostic criteria established by the existing literature, the clinical and radiological presentation, the presence of risk factors, a positive serology for Toxocara canis (IgGELISA) and the absence of alternative diagnosis were considered sufficient criteria to establish toxocariasis with inflammatory lesions in the nasopharynx and pons as the most probable diagnosis. Treatment with albendazole (400 mg / 12 h) and corticosteroids (1 mg / kg for 5 days) was started and continued for one month. Post treatment negative serology, and MRI and CT post treatment controls were performed after one year, both showing a decrease in lesion of the clivus as well as the pons.

conclusionsWith the appropriate personal history, toxocariasis should be included in the differential diagnosis of infiltrating lesions of the skull base with a negative study of tumor histology. Albendazole treatment has been shown to control and cure the disease.

Indexed as

Toxocara canisToxocariasisAlbendazoleAnimalsBrain StemHumansMaleMiddle AgedSkull BaseAlbendazole

Identifiers

PMID34895158
PMCPMC8665590
OpenAlexW4200238690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.